Procalcitonin amplifies inducible nitric oxide synthase gene expression and nitric oxide production in vascular smooth muscle cells

Critical Care Medicine

Volumn 30, Issue 9, 2002, Pages 2091-2095

  Hoffmann, Georg ^a   Czechowski, Monika ^a   Schloesser, Michaela ^a   Schobersberger, Wolfgang ^a  

^a UNIVERSITY OF BONN   (Germany)

Author keywords

Cytokines; Infection; Nitric oxide; Procalcitonin; Sepsis; Septic shock

Indexed keywords

GAMMA INTERFERON; GENE PRODUCT; LIPOPOLYSACCHARIDE; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; PROCALCITONIN; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ARTICLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; CORRELATION ANALYSIS; GENE EXPRESSION REGULATION; HORMONE ACTION; IN VITRO STUDY; INFLAMMATION; NONHUMAN; OXIDATIVE STRESS; PATHOPHYSIOLOGY; PRIORITY JOURNAL; RAT; SEPSIS; SIGNAL TRANSDUCTION; TRANSCRIPTION REGULATION; VASCULAR SMOOTH MUSCLE;

EID: 0036743171     PISSN: 00903493     EISSN: None     Source Type: Journal    
DOI: 10.1097/00003246-200209000-00023     Document Type: Article

References (23)

1. Assicot M, Gendrel D, Carsin H, et al: High serum procalcitonin concentrations in patients with sepsis and infection. Lancet 1993; 341:515-518
2. Gendrel D, Assicot M, Raymond J, et al: Procalcitonin as a marker for the early diagnosis of neonatal infection. J Pediatr 1996; 128:570-573
3. Gendrel D, Raymond J, Assicot M, et al: Procalcitonin, C-reactive protein and interleukin 6 in bacterial and viral meningitis in children. Presse Med 1998; 27:1135-1139
4. Al Nawas B, Krammer I, Shah PM: Procalcitonin in diagnosis of severe infections. Eur J Med Res 1996; 1:331-333
5. Lind L, Bucht E, Ljunghall S: Pronounced elevation in circulating calcitonin in critical care patients is related to the severity of illness and survival. Intensive Care Med 1995; 21:63-66
6. Dandona P, Nix D, Wilson MF, et al: Procalcitonin increase after endotoxin injection in normal subjects. J Clin Endocrinol Metab 1994; 79:1605-1608
7. Nijsten MW, Olinga P, The TH, et al: Procalcitonin behaves as a fast responding acute phase protein in vivo and in vitro. Crit Care Med 2000; 28:458-461
8. Nylen ES, Whang KT, Snider RH Jr, et al: Mortality is increased by procalcitonin and decreased by an antiserum reactive to procalcitonin in experimental sepsis. Crit Care Med 1998; 26:1001-1006
9. Monneret G, Pachot A, Laroche B, et al: Procalcitonin and calcitonin gene-related peptide decrease LPS-induced tnf production by human circulating blood cells. Cytokine 2000; 12:762-764
10. Hoffmann G, Schobersberger W: Procalcitonin inhibits tumor necrosis factor-a gene expression in vascular smooth muscle cells. Cytokine 2001; 14:127-128
11. Hoffmann G, Totzke G, Seibel M, et al: In vitro modulation of inducible nitric oxide synthase gene expression and nitric oxide synthesis by procalcitonin. Crit Care Med 2001; 29:112-116
12. Hoffmann G, Ko Y, Sachinidis A, et al: Kinetics of Na+/H+ exchange in vascular smooth muscle cells from WKY and SHR: Effects of phorbol ester. Am J Physiol 1995; 268:C14-C20
13. Steinwald PM, Whang KT, Becker KL, et al: Elevated calcitonin precursor levels are related to mortality in an animal model of sepsis. Crit Care (Lond) 1999; 3:11-16
14. Schmidt J, Meisner M, Tschaikowski K, et al: Procalcitonin moduliert die proinflammatorische Zytokinfreisetzung in vitro. Anaesthesiol Intensivmed Notfallmed Schmerzther 1997; 32:171
15. Beutler B, Grau GE: Tumor necrosis factor in the pathogenesis of infectious diseases. Crit Care Med 1993; 21:S423-S435
16. Waage A, Halstensen A, Espevik T: Association between tumour necrosis factor in serum and fatal outcome in patients with meningococcal disease. Lancet 1987; 1:355-357
17. Brunkhorst FM, Heinz U, Forycki ZF: Kinetics of procalcitonin in iatrogenic sepsis. Intensive Care Med 1998; 24:888-889
18. Petijean S, Mackensen A, Engelhardt R, et al: Induction de la procalcitonine circulante apres administration intraveneuse d'endotoxine chez l'homme. Actual Pharm Biol Clin 1994:265-268
19. Kilbourn RG, Traber DL, Szabó C: Nitric oxide and shock. Dis Mon 1997; 43:277-348
20. Ochoa JB, Udekwu AO, Billiar TR, et al: Nitrogen oxide levels in patients after trauma and during sepsis. Ann Surg 1991; 214:621-626
21. Evans T, Carpenter A, Kinderman H, et al: Evidence of increased nitric oxide production in patients with the sepsis syndrome. Circ Shock 1993; 41:77-81
22. Oberhoffer M, Vogelsang H, Russwurm S, et al: Outcome prediction by traditional and new markers of inflammation in patients with sepsis. Clin Chem Lab Med 1999; 37:363-368
23. Wort S, Evans TW: The role of the endothelium in modulating vascular control in sepsis and related conditions. Br Med Bull 1999; 55:30-48